|
YWHAG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.72809996815226E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.36120000049367E-07 |
| Normal-vs-Stage2 |
3.503800E-03 |
| Normal-vs-Stage3 |
1.807890E-04 |
| Normal-vs-Stage4 |
8.38850000000058E-05 |
| Stage1-vs-Stage2 |
9.383000E-01 |
| Stage1-vs-Stage3 |
4.840800E-01 |
| Stage1-vs-Stage4 |
3.470400E-01 |
| Stage2-vs-Stage3 |
6.452200E-01 |
| Stage2-vs-Stage4 |
5.317400E-01 |
| Stage3-vs-Stage4 |
8.567200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20690002436419E-09 |
| Normal-vs-AfricanAmerican |
1.498820E-01 |
| Normal-vs-Asian |
2.503200E-01 |
| Caucasian-vs-AfricanAmerican |
3.978200E-02 |
| Caucasian-vs-Asian |
5.026400E-01 |
| AfricanAmerican-vs-Asian |
3.381000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.05199999717232E-08 |
| Normal-vs-Female |
1.05709999997927E-06 |
| Male-vs-Female |
9.894800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.294300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.8086999997724E-07 |
| Normal-vs-Age(61-80Yrs) |
1.29529999948197E-07 |
| Normal-vs-Age(81-100Yrs) |
2.538200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.452200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.443200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.180600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.211800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.984000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.428000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.783700E-02 |
| Normal-vs-Grade 2 |
7.21719999985382E-07 |
| Normal-vs-Grade 3 |
4.36360000000136E-06 |
| Normal-vs-Grade 4 |
1.97512999999816E-05 |
| Grade 1-vs-Grade 2 |
9.618000E-01 |
| Grade 1-vs-Grade 3 |
9.740800E-01 |
| Grade 1-vs-Grade 4 |
1.812640E-01 |
| Grade 2-vs-Grade 3 |
8.187800E-01 |
| Grade 2-vs-Grade 4 |
4.152400E-02 |
| Grade 3-vs-Grade 4 |
3.293800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.85900000013473E-07 |
| Normal-vs-ccB subtype |
5.74420000454268E-08 |
| ccA subtype-vs-ccB subtype |
5.513500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.60149999986581E-07 |
| Normal-vs-N1 |
2.694300E-02 |
| N0-vs-N1 |
1.861770E-01 |
|
|
